Decoy Therapeutics Inc. (DCOY)
CIK 1615219 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Decoy Therapeutics Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 2, 2026 | 4 | 0001233253-26-000006 |
| Sep 2, 2026 | 4 | 0001193125-26-380584 |
| Sep 2, 2026 | 4 | 0002148287-26-000002 |
| Sep 2, 2026 | 4 | 0002079512-26-000002 |
| Sep 2, 2026 | 4 | 0001229055-26-000002 |
| Sep 2, 2026 | 4 | 0002079859-26-000002 |
| Sep 2, 2026 | 4 | 0001457289-26-000003 |
| Sep 2, 2026 | 4 | 0001634368-26-000003 |
| Sep 2, 2026 | 4 | 0001329154-26-000003 |
| Sep 2, 2026 | 4 | 0001769749-26-000003 |
| Aug 14, 2026 | SCHEDULE 13G | 0001172661-26-003569 |
| Aug 12, 2026 | 10-Q | 0001193125-26-346852 |
| Aug 4, 2026 | DEFA14A | 0001193125-26-332792 |
| Aug 4, 2026 | DEF 14A | 0001193125-26-332762 |
| Jul 31, 2026 | 3 | 0001193125-26-328787 |
| Jul 24, 2026 | PRE 14A | 0001193125-26-316072 |
| Jul 17, 2026 | EFFECT | 9999999995-26-002352 |
| Jul 17, 2026 | 424B3 | 0001193125-26-307982 |
| Jul 15, 2026 | 8-K | 0001193125-26-304949 |
| Jul 10, 2026 | S-1 | 0001193125-26-300954 |
| Jun 29, 2026 | 8-K | 0001193125-26-286737 |
| Jun 24, 2026 | EFFECT | 9999999995-26-002113 |
| Jun 15, 2026 | S-1 | 0001193125-26-269891 |
| Jun 5, 2026 | RW | 0001193125-26-259729 |
| Jun 4, 2026 | DEFA14A | 0001193125-26-256546 |